Media Center

Our location for news, announcements and insider perspectives.

 

Ironwood Capital Precision Manufacturer MMG in the News

By on , In the News

Momentum Manufacturing Group (MMG), an Ironwood Capital portfolio company, was recently featured on the cover of The Fabricator magazine. MMG, formerly known as NSA Industries, is one of the top 10 specialty manufacturing companies in the United States.  It offers end-to-end metal and contract manufacturing capabilities.  Momentum Manufacturing Group, an Ironwood Capital portfolio company, was […]

How Pete & Pete’s acquisition of Boyas Excavating has laid the groundwork for the company’s continued growth

By on , In the News

Ironwood Capital portfolio company Pete & Pete and its 2019 acquisition of Boyas Excavating is featured in the May-June edition of Waste Today magazine. http://magazine.wastetodaymagazine.com/article/may-june-2020/in-it-for–the-long-haul.aspx “For Ironwood, the thesis for the transaction was highly compelling: significant growth potential in a region with strong C&D generation, the proximity of Boyas to Pete & Pete, strategic geographical […]

Carolyn Galiette Named to 2020 list of Mergers & Acquisitions’ Most Influential Women in Mid-Market M&A

By on , In the News

Ironwood Capital President and Chief Investment Officer Carolyn Galiette has been named to the 2020 list of Mergers & Acquisitions’ Most Influential Women in Mid-Market M&A.  Ironwood Capital is a Connecticut-based private equity firm that provides non-control growth capital to middle market companies.  Carolyn Galiette, president and chief investment officer, Ironwood Capital Carolyn chairs Ironwood […]

Payveris Closes $7M Series D Round – Funding to Further Accelerate Growth and Platform Expansion

By on , In the News

CROMWELL, Conn., June 13, 2019 (GLOBE NEWSWIRE) — Payveris LLC, the fastest-growing provider of digital money movement technology to financial institutions, announced the completion of the company’s Series D funding round to accelerate client acquisition, platform innovation and the scale-up of the organization as the company continues its rapid growth. Silicon Valley-based Mosaik Partners, which led […]

IsoPlexis Completes $25 Million Series C Financing

By on , In the News

BRANFORD, Conn., May 14, 2019/PRNewswire/ — IsoPlexis, a company focused on advancing single-cell biomarkers to address critical challenges in oncology & beyond, today announced that it had raised $25 million in Series C funding. The round was led by Northpond Ventures and included new strategic investment along with current investors Spring Mountain Capital, Ironwood Capital, North Sound Capital, and […]

Merrill Industries LLC, Ironwood Capital Connecticut Portfolio Company, in the News

By on , In the News

Ironwood Capital Connecticut portfolio company Merrill Industries LLC was recently featured in Boxscore, a publication of the Independent Packaging Association. Merrill Industries is a niche manufacturer of innovative packaging solutions.  Rick Wheeler, Merrill CEO, was interviewed for the article.  In the article, Wheeler summarized what it takes to succeed when rebranding your company,”‘I just can’t […]

P2 Science, Ironwood Capital Connecticut Portfolio Company, Opens Green Chemistry Plant in Naugatuck

By on , In the News

REPRINTED from Global Cosmetic Industry, September 13, 2018 Biorenewable chemistry company P2 Science Inc. has celebrated the opening of its latest Naugatuck, Connecticut facility with a ribbon-cutting ceremony. With commercial production starting in October, the green chemistry advanced manufacturing plant will focus on creating renewable intermediates and ingredients for the fragrances, flavors and cosmetics industry. […]

Ironwood Capital Connecticut Portfolio Company IsoPlexis: Response noted in non-Hodgkin patients

By on , In the News

Reprinted from BioCT, June 22, 2018 IsoPlexis has announced the publication of clinical data demonstrating a significant association between the functionality of anti-CD19 CAR-T cell product before treatment, as defined by IsoPlexis’ Polyfunctional Strength Index (PSI), and the objective response in patients with non-Hodgkin lymphoma. “We were excited to collaborate on this groundbreaking research,” said […]